Personalized Ventilator Settings for Acute Respiratory Distress Syndrome

(PEEPECMO Trial)

This trial examines the optimal use of ventilators for individuals with Acute Respiratory Distress Syndrome (ARDS) who are on ECMO, a life support system aiding the heart and lungs. Researchers aim to determine if a personalized approach to setting the ventilator's PEEP (Personalized Positive End-Expiratory Pressure, which keeps the lungs open) is more effective than the standard method. This approach seeks to reduce further lung injury, promoting more effective healing. Individuals who have undergone or are awaiting a lung or heart transplant may be suitable candidates for this trial. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could enhance ventilator use for future patients.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Research has shown that personalized Positive End-Expiratory Pressure (PEEP) is generally safe for patients with acute respiratory distress syndrome (ARDS). In some studies, patients who received personalized PEEP experienced no major side effects, indicating it is well-tolerated in medical settings. However, minor issues can occur. For instance, one study found that setting up the equipment might cause small problems, such as nosebleeds, in about 8.7% of cases.

Researchers are excited about personalized Positive End-Expiratory Pressure (PEEP) because it tailors ventilator settings to each patient with Acute Respiratory Distress Syndrome (ARDS), potentially improving outcomes. Unlike standard ventilator settings, which use a one-size-fits-all approach, personalized PEEP adjusts the pressure to better match individual patient needs while on ECMO (extracorporeal membrane oxygenation). This customization could lead to more effective breathing support and potentially faster recovery, making it a promising advancement in ARDS treatment strategies.

Research has shown that customizing Positive End-Expiratory Pressure (PEEP) can improve lung function in people with Acute Respiratory Distress Syndrome (ARDS). In this trial, participants will join different treatment arms, including one with personalized PEEP settings. Studies have found that a personalized PEEP approach can enhance oxygen levels and ease lung expansion. This tailored PEEP reduces lung stress and the effort needed to breathe without causing harm. However, while higher PEEP levels might improve oxygen levels, they could also affect blood circulation. Overall, adjusting PEEP settings to fit the individual may better protect the lungs during mechanical ventilation.⁴⁵⁶⁷⁸